Anemia in CKD

KDIGO is developing an update to the 2012 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD). The guideline is designed to apply to a broad population of patients with anemia and CKD. The goal of the guideline is to generate a useful resource for clinicians and patients by providing actionable recommendations, based on a rigorous, formal evidence review, supplemented by practice points and useful infographics to aid in implementation. Special consideration will be given to patient-specific characteristics such as CKD severity (including dialysis), pediatric CKD, kidney transplant recipients, patients on ESA and HIF-PHI therapy, comorbid conditions, and iron deficiency without anemia. In addition, particular attention will be given to patient preference, accessibility, and cost. 

Another aim is to propose research recommendations for areas in which there are gaps in knowledge. Dr. Jodie Babbitt (United States) and Dr. Angela Webster (Australia) will co-chair the guideline.


This Clinical Practice Guideline is based upon the best information available at the time of publication. The recommendations are designed to provide information and assist decision-making. They are not intended to define a standard of care, and should not be construed as one. Neither should they be interpreted as prescribing an exclusive course of management. Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every health care professional making use of this Guideline is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. The recommendations for research contained within this document are general and do not imply a specific protocol.